News on LARGE from BioPortfolio.com http://www.BioPortfolio.com Consolidated LARGE news from BioPortfolio.com Tue, 09 Feb 2010 22:28:46 GMT en Albany Molecular Research Inc. (AMRI) reports 1st Quarter ending March 2010 above estimateshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034006&HITNO=0&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034006&THISHREF=http://c.moreover.com/click/here.pl%3fz2535550509%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034006&HITNO=0&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034006&THISHREF=http://c.moreover.com/click/here.pl%3fz2535550509%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarnings Whispers: Breast Cancer Treatment in Large, Fewer Doses of Radiotherapy Lessens Side Effectshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037912&HITNO=1&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037912&THISHREF=http://c.moreover.com/click/here.pl%3fz2537370157%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037912&HITNO=1&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037912&THISHREF=http://c.moreover.com/click/here.pl%3fz2537370157%26amp%3bz%3d950242273&THEHOST=site+d.moreover.com24-7PressRelease.com: Peroneal artery perforator chimeric flap for reconstruction of composite defects in extremitieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037778&HITNO=2&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037778&THISHREF=http://c.moreover.com/click/here.pl%3fz2537283356%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037778&HITNO=2&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037778&THISHREF=http://c.moreover.com/click/here.pl%3fz2537283356%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMicrosurgery: Wendy White Named to Healthcare BusinesswomenEURs Association 2010 Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037557&HITNO=3&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037557&THISHREF=http://c.moreover.com/click/here.pl%3fz2537140441%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037557&HITNO=3&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037557&THISHREF=http://c.moreover.com/click/here.pl%3fz2537140441%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Large cap pharma space going up on negative diversions: Shardul Kulkarnihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037217&HITNO=4&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037217&THISHREF=http://c.moreover.com/click/here.pl%3fz2536968425%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037217&HITNO=4&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037217&THISHREF=http://c.moreover.com/click/here.pl%3fz2536968425%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEconomictimes: Medical News: Dynavax Initiates Large-Scale Phase 3 Trial Of HEPLISAVTMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036818&HITNO=5&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036818&THISHREF=http://c.moreover.com/click/here.pl%3fz2536769775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036818&HITNO=5&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036818&THISHREF=http://c.moreover.com/click/here.pl%3fz2536769775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Dynavax Initiates Large-Scale Phase 3 Trial Of HEPLISAVTMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036267&HITNO=6&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536544045%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036267&HITNO=6&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536544045%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Pfizer Call Purchasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036266&HITNO=7&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036266&THISHREF=http://c.moreover.com/click/here.pl%3fz2536543938%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036266&HITNO=7&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036266&THISHREF=http://c.moreover.com/click/here.pl%3fz2536543938%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBenzinga.com: Risk of missed doses underestimated, effective guidance programmes neededhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034660&HITNO=8&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034660&THISHREF=http://c.moreover.com/click/here.pl%3fz2535913052%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034660&HITNO=8&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034660&THISHREF=http://c.moreover.com/click/here.pl%3fz2535913052%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033653&HITNO=9&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033653&THISHREF=http://c.moreover.com/click/here.pl%3fz2535307824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033653&HITNO=9&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033653&THISHREF=http://c.moreover.com/click/here.pl%3fz2535307824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033449&HITNO=10&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033449&THISHREF=http://c.moreover.com/click/here.pl%3fz2535208391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033449&HITNO=10&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033449&THISHREF=http://c.moreover.com/click/here.pl%3fz2535208391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: One-Third of Antimalarial Medicines Sampled in Three African Nations Found to be Substandard in Large-Scale USP-WHO Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032316&HITNO=11&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032316&THISHREF=http://c.moreover.com/click/here.pl%3fz2534598977%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032316&HITNO=11&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032316&THISHREF=http://c.moreover.com/click/here.pl%3fz2534598977%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Manufacturing Magazine: AMRI Announces Fourth Quarter 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031623&HITNO=12&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031623&THISHREF=http://c.moreover.com/click/here.pl%3fz2534279686%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031623&HITNO=12&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031623&THISHREF=http://c.moreover.com/click/here.pl%3fz2534279686%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: AMRI Announces Fourth Quarter 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030808&HITNO=13&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030808&THISHREF=http://c.moreover.com/click/here.pl%3fz2533829146%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030808&HITNO=13&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030808&THISHREF=http://c.moreover.com/click/here.pl%3fz2533829146%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: AMRI Announces Fourth Quarter 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028940&HITNO=14&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028940&THISHREF=http://c.moreover.com/click/here.pl%3fz2532918847%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028940&HITNO=14&MSIZE=412&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=LARGE&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028940&THISHREF=http://c.moreover.com/click/here.pl%3fz2532918847%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: